Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 585 - 592 of 11616 results
How Can the Updated USPTO Guidance on Determining Obviousness Help You?
March 7, 2024| Blog| Viewpoint
What’s New in Wireless - March 2024
March 6, 2024| Blog| Viewpoint
FDA Faces Critical Deadlines in 2024, Even Without an Election Looming
March 6, 2024| Blog| Viewpoint
FTC Hosts Panel and Launches Public Inquiry with DOJ and HHS on Private Equity and Health Care
March 6, 2024| Advisory| Viewpoint
Tips For Counsel Seeking Balance In The ESG Political Divide
March 6, 2024| News
Major Drugmakers to Team Up in Court Against Price Negotiations
March 6, 2024| News
How IP Arbitration Lawyers Are Scouting New Leads
March 5, 2024| News
Health Status of Healthcare: Critical Condition
March 5, 2024| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.